Gene · 1448
CSN3: casein kappa
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CSN3: casein kappa. Genes, record 1448. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1448
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P07498 | Kappa-casein | 182 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents35
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40149 | P07498 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4307 | P07498 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 3638 | P07498 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6030 | P07498 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6030 | P07498 | Espacenet |
| WO 2025133158 A2 | 2025-06-26 | 28 | P07498 | Espacenet |
| JP 2025518827 A | 2025-06-19 | 60 | P07498 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4307 | P07498 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 12052 | P07498 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 3638 | P07498 | Espacenet |
1 to 10 of 35
See all 35 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants988
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CSN3 papers | Newest fiscal year |
|---|---|---|---|
| R35GM124889 | Coordination of molecular motor activity in intracellular transport and assembly of cytoskeletal archit | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| R01MH046742 | Differential Resilience in Models of Neurons and Circuits with Similar Outputs | 5 | 2025 |
| ZIADE000438 | Molecular Mechanisms Regulating Calcium Flux In Salivary Glands | 5 | 2025 |
| R01HL092321 | Regulation of Cardiac Calcium Transport | 3 | 2025 |
| R35GM133688 | Defining microtubule cytoskeleton regulatory pathways in development and disease | 3 | 2025 |
| R35GM139483 | Regulation of Dynein-Mediated Transport | 3 | 2025 |
| UL1TR001860 | UC Davis Clinical and Translational Science Center | 3 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 988Source NIH's project files
See all 988 nih grantsPapers2,318
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-genome analysis and molecular docking reveal how nucleotide variations in the aprX gene drive the differential spoilage potential of Pseudomonas in milk. | Food Microbiol | 2027 | 42668199 | PubTator, text mining | PubMed |
| CSN3 promotes colorectal cancer cell progression through activation of the PI3K/AKT/mTOR pathway. | Mol Biol Rep | 2026 | 42821034 | PubTator, text mining | PubMed |
| The cornea-trigeminal axis: potassium channels as master regulators of ocular surface homeostasis and sensory transduction. | Front Cell Dev Biol | 2026 | 42707580 | PubTator, text mining | PubMed |
| Ultrasonic phase velocity as a non-destructive predictor of protein aggregation in retort-processed milk-coffee beverages. | Food Res Int | 2026 | 42562471 | PubTator, text mining | PubMed |
| Beta-casein in human milk is associated with infant stool frequency: A pilot proteomics study. | Physiol Rep | 2026 | 42552957 | PubTator, text mining | PubMed |
| CSN3 promotes gastric cancer progression and is associated with immune infiltration and inflammatory signaling. | Transl Cancer Res | 2026 | 42445438 | PubTator, text mining | PubMed |
| Restoration of membrane potential rescues organelle function via NS309-mediated KCa activation in aged porcine oocytes. | Theriogenology | 2026 | 42430905 | PubTator, text mining | PubMed |
| Somatostatin sharpens the neuronal action potential by increasing K+ and decreasing Ca2+ conductances. | J Neurophysiol | 2026 | 42275181 | PubTator, text mining | PubMed |
| Multivariate association between αS1- and κ-casein variants and semen quality traits in Murciano-Granadina bucks in breeding programs. | J Dairy Sci | 2026 | 42219018 | PubTator, text mining | PubMed |
| Peptidomic Profiling Analysis of Endogenous Peptides in Buffalo Milk During Lactation Stages. | Foods | 2026 | 42195931 | PubTator, text mining | PubMed |
1 to 10 of 2,318
See all 2,318 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1448
GET https://conductscience.org/api/genes/v1/1448/patents?page=2